Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples